JP2023508349A5 - - Google Patents

Info

Publication number
JP2023508349A5
JP2023508349A5 JP2022538471A JP2022538471A JP2023508349A5 JP 2023508349 A5 JP2023508349 A5 JP 2023508349A5 JP 2022538471 A JP2022538471 A JP 2022538471A JP 2022538471 A JP2022538471 A JP 2022538471A JP 2023508349 A5 JP2023508349 A5 JP 2023508349A5
Authority
JP
Japan
Prior art keywords
acid
nle
peptide
lysine
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022538471A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023508349A (ja
Filing date
Publication date
Priority claimed from EP19425098.1A external-priority patent/EP3842061A1/en
Application filed filed Critical
Publication of JP2023508349A publication Critical patent/JP2023508349A/ja
Publication of JP2023508349A5 publication Critical patent/JP2023508349A5/ja
Pending legal-status Critical Current

Links

JP2022538471A 2019-12-23 2020-12-18 グルカゴン受容体およびｇｌｐ－１受容体のステープルトリアゾールコアゴニスト Pending JP2023508349A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19425098.1A EP3842061A1 (en) 2019-12-23 2019-12-23 Stapled triazole co-agonists of the glucagon and glp-1 receptors
EP19425098.1 2019-12-23
PCT/US2020/065796 WO2021133644A1 (en) 2019-12-23 2020-12-18 Stapled triazole co-agonists of the glucagon and glp-1 receptors

Publications (2)

Publication Number Publication Date
JP2023508349A JP2023508349A (ja) 2023-03-02
JP2023508349A5 true JP2023508349A5 (https=) 2023-12-18

Family

ID=69326342

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022538471A Pending JP2023508349A (ja) 2019-12-23 2020-12-18 グルカゴン受容体およびｇｌｐ－１受容体のステープルトリアゾールコアゴニスト

Country Status (10)

Country Link
US (1) US20230063794A1 (https=)
EP (2) EP3842061A1 (https=)
JP (1) JP2023508349A (https=)
KR (1) KR20220119475A (https=)
CN (1) CN115226391A (https=)
AU (1) AU2020412677A1 (https=)
BR (1) BR112022012499A2 (https=)
CA (1) CA3162800A1 (https=)
MX (1) MX2022007929A (https=)
WO (1) WO2021133644A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024532362A (ja) * 2021-08-27 2024-09-05 イエール ユニバーシティ 細胞外タンパク質の分子分解誘導剤
WO2023028590A1 (en) 2021-08-27 2023-03-02 Yale University Molecular degraders of extracellular proteins

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737323A (en) 1986-02-13 1988-04-12 Liposome Technology, Inc. Liposome extrusion method
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
AR008789A1 (es) 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
US6268343B1 (en) * 1996-08-30 2001-07-31 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6054587A (en) 1997-03-07 2000-04-25 Metabasis Therapeutics, Inc. Indole and azaindole inhibitors of fructose-1,6-bisphosphatase
DE69819311T2 (de) 1997-03-07 2004-07-29 Metabasis Therapeutics Inc., San Diego Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
US6284748B1 (en) 1997-03-07 2001-09-04 Metabasis Therapeutics, Inc. Purine inhibitors of fructose 1,6-bisphosphatase
US6613942B1 (en) 1997-07-01 2003-09-02 Novo Nordisk A/S Glucagon antagonists/inverse agonists
BR9810378A (pt) 1997-07-01 2000-08-29 Novo Nordisk As Composto,uso do mesmo, composição farmacêutica, e, processos de tratar a diabete do tipo i ou do tipo ii, de tratar a hiperglicemia, e de diminuir a glicose do sangue em um mamìfero
KR100818845B1 (ko) 1998-09-09 2008-04-01 메타베이시스 테라퓨틱스, 인크. 신규한 프럭토스 1,6-비스포스파타제의 헤테로방향족 억제제
DE60023492T2 (de) 1999-05-17 2006-07-20 Novo Nordisk A/S Glucagon antagonisten/inverse agonisten
US6677136B2 (en) * 2000-05-03 2004-01-13 Amgen Inc. Glucagon antagonists
AU7705601A (en) 2000-07-25 2002-02-05 Merck & Co Inc N-substituted indoles useful in the treatment of diabetes
EP1357908A4 (en) 2001-01-30 2009-07-15 Merck & Co Inc "ACYLSULFAMIDES FOR THE TREATMENT OF FATIBILITY, DIABETES AND LIPID DISORDERS"
GB0121709D0 (en) 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
AR040241A1 (es) 2002-06-10 2005-03-23 Merck & Co Inc Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
CN100457730C (zh) 2002-08-29 2009-02-04 默克公司 具有抗糖尿病活性的吲哚化合物
EP1546142A4 (en) 2002-08-29 2007-10-17 Merck & Co Inc INDOLES HAVING ANTIDIABETIC EFFECT
JO2397B1 (en) 2002-12-20 2007-06-17 ميرك شارب اند دوم كوربوريشن Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors
GB0300571D0 (en) 2003-01-10 2003-02-12 Imp College Innovations Ltd Modification of feeding behaviour
AU2004207444B2 (en) 2003-01-17 2008-07-31 Merck & Co., Inc. N-cyclohexylaminocarbonyl benzenesulfonamide derivatives
EP1888031B1 (en) * 2005-06-06 2013-01-23 Camurus Ab Glp-1 analogue formulations
ATE553124T1 (de) 2005-06-13 2012-04-15 Imp Innovations Ltd Oxyntomodulinanaloga und ihre wirkungen auf das fressverhalten
US8175737B2 (en) 2006-07-19 2012-05-08 Freescale Semiconductor, Inc. Method and apparatus for designing and integrated circuit
CA2677932A1 (en) * 2007-02-15 2008-08-21 Indiana University Research And Technology Corporation Glucagon/glp-1 receptor co-agonists
CN101743616B (zh) 2007-06-28 2012-02-22 株式会社半导体能源研究所 半导体装置的制造方法
CA2691010A1 (en) 2007-06-28 2008-12-31 Merck Frosst Canada Ltd. Substituted fused pyrimidines as antagonists of gpr105 activity
EP2178537A4 (en) 2007-07-19 2011-08-17 Merck Sharp & Dohme BETA-CARBOLIN DERIVATIVES AS ANTIDIBLE COMPOUNDS
US20110301079A1 (en) 2007-09-21 2011-12-08 Instituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Neuromedin u receptor agonists and uses thereof
AR072160A1 (es) * 2008-06-17 2010-08-11 Univ Indiana Res & Tech Corp Co-agonistas del receptor de glucagon/glp-1
WO2010096052A1 (en) 2009-02-19 2010-08-26 Merck Sharp & Dohme Corp. Oxyntomodulin analogs
US8703701B2 (en) 2009-12-18 2014-04-22 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
RS56173B1 (sr) * 2011-06-22 2017-11-30 Univ Indiana Res & Tech Corp Koagonisti receptora za glukagon/glp-1 receptora
KR20140043793A (ko) 2011-06-22 2014-04-10 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 글루카곤/glp-1 수용체 공동-작용물질
CA2935026C (en) * 2014-01-15 2018-11-13 Fyziologicky Ustav Akademie Ved Cr, V.V.I. Lipidated prolactin-releasing peptides for lowering blood glucose
CN107108715A (zh) * 2014-10-24 2017-08-29 默沙东公司 胰高血糖素和glp‑1受体的共激动剂
EP3377521A4 (en) * 2015-10-27 2019-05-01 Merck Sharp & Dohme Corp. LONG-ACTING CO AGONISTS OF GLUCAGON AND GLP-1 RECEPTORS
WO2017189342A1 (en) * 2016-04-26 2017-11-02 Merck Sharp & Dohme Corp. Insulin dimer-incretin conjugates
US11566057B2 (en) 2017-09-25 2023-01-31 Merck Sharp & Dohme Llc Long-acting co-agonists of the glucagon and GLP-1 receptors
CN109836503B (zh) * 2017-11-24 2022-09-16 浙江道尔生物科技有限公司 一种治疗代谢疾病的多重活性蛋白
CN109836488B (zh) * 2017-11-24 2022-08-23 浙江道尔生物科技有限公司 一种治疗代谢疾病的胰高血糖素类似物
WO2019157362A1 (en) * 2018-02-09 2019-08-15 Healthtell Inc. Array-based cyclic peptide libraries

Similar Documents

Publication Publication Date Title
CN110023329B (zh) 作为肽类三重glp1/胰高血糖素/gip受体激动剂的新化合物
AU2005271878B2 (en) Compositions for delivering peptide YY and PYY agonists
JP5820349B2 (ja) 膵臓ポリペプチドファミリーモチーフ、ポリペプチドおよびこれらを含む方法
JP6298044B2 (ja) グルカゴン様ペプチド−２（ｇｌｐ−２）類似体
WO2022268029A1 (zh) Glp-1、gcg和gip受体的三重激动剂
ES2541633T3 (es) Exendinas modificadas y usos de las mismas
JP5801807B2 (ja) 修飾された血管作動性腸管ペプチド
CN102292346B (zh) 肥胖的治疗
JP5743371B2 (ja) 膵臓ポリペプチドファミリーモチーフ、ポリペプチドおよびこれらを含む方法
AU2025202650A1 (en) ELP fusion proteins for controlled and sustained release
US20180280480A1 (en) Compositions and peptides having dual glp-1r and glp-2r agonist activity
AU2019323697B2 (en) Acylated calcitonin mimetics
US20140213518A1 (en) Methods of enhancing functioning of the large intestine
JP2018100279A (ja) ペグ化ｏｘｍ変異体
HRP20201353T1 (hr) Agonisti glukagonskog receptora
CN1551780A (zh) 用于预防或治疗体重过重的胃肠激素
CN109996557A (zh) 作为肽类glp1/胰高血糖素/gip受体激动剂的新化合物
JP2023508349A5 (https=)
JP2011511778A5 (https=)
KR102019911B1 (ko) 질병 및 장애 치료용 펩타이드 유사체
WO2012031518A1 (zh) Exendin-4类似物的定位聚乙二醇化修饰物及其用途
RS58530B1 (sr) Mimetici kalcitonina za lečenje bolesti i poremećaja
US20240360193A1 (en) Polypeptide derivative with dual glp-1r and gipr targeting agonistic effect, and preparation method and use thereof
AU2015207776B2 (en) Lipidated peptides for lowering blood glucose
JP2023508347A5 (https=)